Other genes that are differentially expressed in Bhas 42 CTA by TPA treatment include RAN, MTHFD2, WT1, and AURORA-A, which are markers that cause cancer formation and malignant transformation in humans and laboratory animals. This evidence concerns the gene RAN and cancer.